Division of Electrophysiology, Department of Cardiology, North Shore University Hospital, Manhasset, New York.
Department of Medicine, North Shore University Hospital, Manhasset, New York.
J Cardiovasc Electrophysiol. 2020 Apr;31(4):860-867. doi: 10.1111/jce.14390. Epub 2020 Feb 21.
The need for transvenous lead extractions due to cardiac implantable electronic device (CIED)-related infections continues to rise. Current guidelines recommend complete device removal in the setting of an active infection, which can be challenging in pacemaker-dependent patients.
We retrospectively reviewed all leadless pacemaker implants between January 2018 and November 2019 and identified a subset of patients who had undergone a concomitant CIED extraction in the setting of an active infection. Baseline characteristics, procedural details, and clinical follow-ups were recorded.
Seventeen patients received a leadless pacemaker during the same procedure as the CIED extraction. There were no procedural complications. All patients were being treated for an active CIED infection at the time of the procedure. Fourteen patients (82.4%) were completely pacemaker-dependent and four patients (23.5%) had positive blood cultures at the time of the leadless pacemaker implantation. During a median follow-up of 143 days (interquartile range: 57, 181 days), there were no recurrent infections.
Simultaneous leadless pacemaker implantation and CIED extraction are safe and feasible in the setting of an active infection. This strategy may be particularly useful in patients that are pacemaker-dependent.
由于与心脏植入式电子设备(CIED)相关的感染,需要进行经静脉导线拔除的情况持续增加。目前的指南建议在有活动性感染的情况下,应完全移除设备,但对于依赖起搏器的患者来说,这可能具有挑战性。
我们回顾性分析了 2018 年 1 月至 2019 年 11 月期间所有无导线起搏器的植入病例,并确定了一组在活动性感染情况下同时进行 CIED 拔除的患者亚组。记录了基线特征、手术细节和临床随访情况。
17 名患者在 CIED 拔除的同时接受了无导线起搏器。无手术并发症。所有患者在手术时均患有活动性 CIED 感染。14 名患者(82.4%)完全依赖起搏器,4 名患者(23.5%)在植入无导线起搏器时血液培养阳性。在中位数为 143 天(四分位距:57,181 天)的随访中,没有再发生感染。
在活动性感染的情况下,同时进行无导线起搏器植入和 CIED 拔除是安全且可行的。这种策略在依赖起搏器的患者中可能特别有用。